China Biologic Products Holdings Inc (CBPO)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

18TH FL, JIALONG INTERNATIONALBUILDING BEIJING, CHINA 100125

China Biologic Products Holdings, Inc. operates as a biopharmaceutical company. The Company researches, develops, and produces human plasma-based pharmaceutical and coagulation factor products in the form of tablets, injections, capsules, and syrups. China Biologic Products also distributes pharmaceutical products. China Biologic Products serves clients in China.

Data based on most recent fiscal year report
Market Cap4.581 Billion Shares Outstanding39.36 Million Avg Volume213.793 Thousand
1-Yr BETA vs S&P TR0.139 Current Ratio11.09 Quick Ratio9.1
View SEC Filings from CBPO instead.

View recent insider trading info

Funds Holding CBPO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CBPO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CUI XIANGMIN

  • Director
  • 10% Owner
0 2020-01-02 0

KUO YUYUN TRISTAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-12-31 0

LIU ZHIJING CBPO CORPORATE VICE PRESIDENT

  • Officer
4,611 2017-05-08 0

SHAO SEAN

  • Director
20,000 2017-03-01 0

GAO DAVID CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
395,347 2017-02-28 0

YEUNG ALBERT

  • Director
45,000 2016-12-09 0

LIU WENFANG

  • Director
3,383 2016-08-15 0

YANG MING CHIEF FINANCIAL OFFICER

  • Officer
24,782 2016-08-15 0

YIN MING SR. CORPORATE VICE PRESIDENT

  • Officer
16,467 2016-08-15 0

YANG GANG CBPO CORPORATE VICE PRESIDENT

  • Officer
32,242 2016-08-15 0

LI DAVID HUI

  • Director
269 2016-08-11 0

FANG MIN

  • Director
7,417 2016-08-11 0

LU YUNGANG

  • Director
18,000 2016-08-04 0

TONG ZHIJUN

  • Director
12,000 2016-08-04 0

CHOW JOSEPH

  • Director
10,000 2016-08-04 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X GP L.P.

WPP GP LLC

WARBURG PINCUS PARTNERS, L.P.

WARBURG PINCUS PARTNERS GP LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

WP X BIOLOGICS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
No longer subject to file 2016-06-08 0

KITT BARRY M

  • 10% Owner
4,363,589 2015-12-31 0

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • 10% Owner
No longer subject to file 2014-08-12 0

FENG DAI

  • Director
10,989,200 2014-05-04 0

LI BING

  • Director
5,000 2013-08-16 0

ZHANG LE

  • Director
5,000 2013-08-16 0

LI LIN LING

  • SEE REMARKS
No longer subject to file 2013-05-14 0

WP X BIOLOGICS LLC

WARBURG PINCUS PRIVATE EQUITY X, L.P.

WARBURG PINCUS X PARTNERS, L.P.

WARBURG PINCUS X, L.P.

WARBURG PINCUS X LLC

WARBURG PINCUS PARTNERS LLC

WARBURG PINCUS & CO.

WARBURG PINCUS LLC

KAYE CHARLES R

LANDY JOSEPH P.

  • Director
  • 10% Owner
10,989,200 2013-05-14 0

ZHAO CHAO MING PRESIDENT

  • Officer
621,787 2012-11-28 0

ZHANG HAN

  • Director
0 2012-04-20 0

LIN TONG JUN

  • Director
0 2011-01-01 0

LI CHONG YANG

  • Director
0 2010-12-17 0

CHAN LING SIU

  • Director
  • 10% Owner
5,362,624 2010-12-13 0

GAN JIE

  • Director
0 2008-07-24 0

WONG CBPO STANLEY CHIEF EXECUTIVE OFFICER

  • Officer
0 2008-05-09 0

PANG GUANG LI

  • Director
0 2008-05-09 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments